{
    "ucits": true,
    "type": "ETF",
    "leverage": false,
    "derivatives": false,
    "swaps": false,
    "inverse": false,
    "replication_method": "physical",
    "complex_factors": "",
    "classification": "non-complex",
    "supporting_data": "The JPM China A Research Enhanced Index Equity Active UCITS ETF is a UCITS-compliant ETF that pursues an actively managed strategy primarily investing in China A shares. It aims to outperform the MSCI China A Index but does not seek to synthetically replicate the index. The ETF may use derivatives only for efficient portfolio management purposes, which is limited and does not form an integral part of the investment strategy. There is no indication of embedded derivatives, leverage beyond UCITS limits, or complex structured products such as CLOs. The replication method is physical, holding underlying securities rather than synthetic replication. The ETF's structure, risks (market volatility, currency risk), and payoff are straightforward and transparent to retail investors with basic knowledge. The ETF does not embed complex features such as contingent convertible bonds, significant leverage, or opaque indices. Securities lending, if any, is managed within UCITS rules and does not dominate the risk profile. The ETF's risk rating reflects market volatility, not structural complexity. According to MiFID II Article 254, Delegated Regulation EU 2017/565 Article 57, and ESMA guidelines, such a UCITS ETF with physical replication, limited derivative use for EPM, and transparent structure is classified as non-complex. Therefore, no appropriateness assessment or comprehension alert is required for retail investors under MiFID II. This assessment aligns with ESMA and CESR guidance that UCITS ETFs investing physically without embedded derivatives or complex structures are non-complex instruments. The ETF's active management and ESG integration do not introduce complexity under MiFID II criteria. Hence, the classification is non-complex."
}